Myra Wang Imanaka is a eficient expert, who works in Allen Institute main office of which is in 77. on the position of Science and Technology Innovation Manager since 2019. This expert has earned professional experience in more than six positions at various companies. Myra Wang Imanaka went to the University of Washington and was studying there from 2004 to 2010. Seattle, Washington is the city, where this person was known to settle. This professional's e-mail and phone are accessed through this website by request.
Name variants:
Mira Imanaka
Contact Information
Last Update
Jul 7, 2022
Email
mw**@kinetabio.com
Location
Seattle, WA
Company
Allen Institute
Workplace
Science and Technology Innovation Manager
Work History
Science and Technology Innovation Manager
615 Westlake Ave north, Seattle, WA 98109
from Sep 2019
Technology Manager, Business Development
1100 Fairview Ave north, Seattle, WA 98109
Business Development and Strategy
Engage with investigators, industry, and collaborators to achieve successful financial and research partnerships.
Work with a variety of life science and...
Aug 2016 — Sep 2019
Associate Director - Intellectual Property
401 Terry Ave north, Seattle, WA 98109
KPI Therapeutics Inc. is a sister company of Kineta, Inc. that is structured to manage the partnering and commercializing of several Kineta-developed assets. I led the KPI/Kineta in-house I...
Jan 2016 — Jul 2016
Associate Director, Intellectual Property Strategy
Seattle, WA
Kineta is focused on the preclinical development of drugs that modulate the human (host) innate immune system for indications including autoimmune disorders, chronic pain, and viral infectio...
Mar 2014 — Jan 2016
Senior Scientist, Program Management and Virology
Seattle, WA
As a research scientist at Kineta, I conducted high-throughput screening (HTS) methods to identify small molecules that modulate the host innate immune response. I developed medium- to high-...
May 2010 — Mar 2014
Graduate Research Assistant
1100 Fairview Ave north, Seattle, WA 98109
Overexpression of the oncogene c-Myc in primary cells does not result in the irreversible cell cycle arrest known as oncogene-induced senescence (OIS) and instead proliferates to an immortal...
Mar 2006 — May 2010
Education
2004 — 2010
2000 — 2004
Occupations
Executive
Manager
Scientist
Biotechnology Professional
Technology Manager
Operations Manager
Biologist
Biological Scientist
Technical Managers
Skills
Drug Discovery
Biotechnology
Life Sciences
Intellectual Property
Molecular Biology
Clinical Development
Technology Transfer
Drug Development
Patent Portfolio Analysis
Patents
Patent Prosecution
Patent Applications
Business Development
Program Management
Project Management
Cell Biology
Patent Law
Drafting Patent Applications
Patent Strategy
Virology
Technology Management
Contract Management
R&D
Immunology
Biochemistry
Consulting
Pre Clinical Studies
International Intellectual Property
Federal Grants Management
Small Molecules
Biologics
Disclosure
In Vitro
In Vivo